After five years of arduous synthesis and testing, Stirling's researchers came up with their first promising tweak of thalidomide, Revlimid, by moving one oxygen atom and adding a bit of ammonia.
He also advocates other technologies still controversial: adding enzymes (to enhance wine's color) or adding microbubbles of oxygen (to speed its aging).